液相色谱串联质谱助力慢性肾脏病患者甲状旁腺激素测量标准化
研究以WHO 95/646国际标准校准的LC-MS/MS方法为参考,对五种PTH免疫测定进行重新校准,评估标准化可行性。重新校准成功降低了测定间变异性,使不同测定的PTH测量结果趋于一致,并展示了采用共同参考范围的可行性。
要点
- 以LC-MS/MS为参考重新校准五种PTH免疫测定,可降低测定间变异性。
- 基于WHO 95/646国际标准校准后,不同PTH测定结果可实现 harmonization。
- 标准化PTH测量有助于更一致地解读PTH值和临床决策。
核心结论
- 以LC-MS/MS方法为参考重新校准PTH免疫测定,可降低测定间变异性并使PTH测量结果趋于一致。
- 基于WHO 95/646国际标准校准后,采用共同参考范围具有可行性。
研究设计与样本
- 利用经WHO 95/646国际标准校准的LC-MS/MS方法测定PTH浓度的大panel混合血浆样本。
- 对五种PTH免疫测定进行重新校准,并使用不同样本集评估标准化的稳健性。
主要发现
- 重新校准成功降低了测定间变异性,使不同测定的PTH测量结果趋于一致。
- 基于WHO 95/646国际标准校准后,展示了标准化PTH测量结果和采用共同参考范围的可行性。
关键数值与推荐
- 以经WHO 95/646国际标准校准的LC-MS/MS方法作为参考。
- 对五种PTH免疫测定进行重新校准。
临床怎么用
- 重新校准可使不同免疫测定的PTH结果与LC-MS/MS方法对齐,提供更一致和可靠的测量。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Precise determination of circulating parathyroid hormone (PTH) concentration is crucial to diagnose and manage various disease conditions, including the chronic kidney disease-mineral and bone disorder. However, the lack of standardization in PTH assays is challenging for clinicians, potentially leading to medical errors because the different assays do not provide equivalent results and use different reference ranges. Here, we aimed to evaluate the impact of recalibrating PTH immunoassays by means of a recently developed LC-MS/MS method as the reference. Utilizing a large panel of pooled plasma samples with PTH concentrations determined by the LC-MS/MS method calibrated with the World Health Organization (WHO) 95/646 International Standard, five PTH immunoassays were recalibrated. The robustness of this standardization was evaluated over time using different sets of samples. The recalibration successfully reduced inter-assay variability with harmonization of PTH measurements across different assays. By recalibrating the assays based on the WHO 95/646 International Standard, we demonstrated the feasibility for standardizing PTH measurement results and adopting common reference ranges for PTH assays, facilitating a more consistent interpretation of PTH values. The recalibration process aligns PTH results obtained from various immunoassays with the LC-MS/MS method, providing more consistent and reliable measurements. Thus, establishing true standardization across all PTH assays is crucial to ensure consistent interpretation and clinical decision-making.
引用
- Cavalier E, Farré-Segura J, Lukas P, et al. Unveiling a new era with liquid chromatography coupled with mass spectrometry to enhance parathyroid hormone measurement in patients with chronic kidney disease. Kidney Int. 2023. PMID: 37918791. doi:10.1016/j.kint.2023.09.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。